Insider Trading activities of Durata Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Durata Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Durata Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Durata Therapeutics, Inc. since 2005. The reporting company's ticker symbol is DRTX. The reporting company's CIK number is 1544116.
The total value of stock buying since 2005 is $99,223,412.
The total value of stock sales since 2005 is $1,583,873.
The total value of stock option exercises since 2005 is $20,940.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Durata Therapeutics, Inc. (DRTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2014-08 3,000 $41,160 0 $0 10,068 $20,940
2014-06 3,000 $45,690 0 $0 0 $0
2014-05 15,000 $233,505 0 $0 0 $0
2014-03 0 $0 100,649 $1,583,873 0 $0
2013-12 1,000 $10,950 0 $0 0 $0
2013-05 3,000 $21,267 0 $0 0 $0
2012-08 5,500 $47,375 0 $0 0 $0
2012-07 10,980,385 $98,823,465 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Durata Therapeutics, Inc. insiders (DRTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-08-26 Canaan Viii Lp (Director) Option Ex 5,034 2.08 10,470
2014-08-26 Ahrens Brenton Karl (Director) Option Ex 5,034 2.08 10,470
2014-08-12 Shannon John Patrick Jr (Chief Commercial Officer) Buy 3,000 13.72 41,160
2014-06-12 Edick Paul R (Chief Executive Officer) Buy 3,000 15.23 45,690
2014-05-12 De Schutter Richard U (Director) Buy 15,000 15.57 233,505
2014-03-21 Elms Steve Sale 2,649 15.57 41,255
2014-03-20 Elms Steve Sale 98,000 15.74 1,542,618
2013-12-03 Giles Lisa M. (Director) Buy 1,000 10.95 10,950
2013-05-20 Edick Paul R (Chief Executive Officer) Buy 3,000 7.09 21,267
2012-08-14 Edick Paul R (Chief Executive Officer) Buy 5,000 8.65 43,250
2012-08-06 Giles Lisa M. (Director) Buy 500 8.25 4,125
2012-07-24 Canaan Partners Viii Llc (Director) Buy 555,555 9.00 4,999,995
2012-07-24 Domain Partners Viii, L.p. (10% Owner) Buy 778,536 9.00 7,006,824
2012-07-24 Dp Viii Associates, L.p. (10% Owner) Buy 5,777 9.00 51,993
2012-07-24 Sofinnova Management Vii, L.l.c. (10% Owner) Buy 588,236 9.00 5,294,124
2012-07-24 Halak Brian K (10% Owner) Buy 784,313 9.00 7,058,817
2012-07-24 Ahrens Brenton Karl (Director) Buy 555,555 9.00 4,999,995
2012-07-24 Akkaraju Srinivas (10% Owner) Buy 784,313 9.00 7,058,817
2012-07-24 Elms Steve Buy 1,111,111 9.00 9,999,999
2012-07-24 Hunt Ronald (Director) Buy 784,313 9.00 7,058,817
2012-07-24 Schoemaker Kathleen K (10% Owner) Buy 784,313 9.00 7,058,817
2012-07-24 Dovey Brian H (10% Owner) Buy 784,313 9.00 7,058,817
2012-07-24 Vitullo Nicole (Director) Buy 784,313 9.00 7,058,817
2012-07-24 Goldstein Dov A Md Buy 1,111,111 9.00 9,999,999
2012-07-24 Blair James C (10% Owner) Buy 784,313 9.00 7,058,817
2012-07-24 Treu Jesse I (10% Owner) Buy 784,313 9.00 7,058,817

Insider trading activities including stock purchases, stock sales, and option exercises of DRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Durata Therapeutics, Inc. (symbol DRTX, CIK number 1544116) see the Securities and Exchange Commission (SEC) website.